日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer

肿瘤内HER2异质性对HER2阳性胃癌患者曲妥珠单抗疗效的临床影响

期刊:Gastric Cancer
影响因子:5.1
doi:10.1007/s10120-026-01736-9
Yoshino, Koichiro; Takamatsu, Manabu; Ooki, Akira; Chin, Keisho; Takahari, Daisuke; Osumi, Hiroki; Ogura, Mariko; Tamba, Mikako; Fukuda, Koshiro; Shimozaki, Keitaro; Udagawa, Shohei; Fukuoka, Shota; Shinozaki, Eiji; Yamaguchi, Kensei; Wakatsuki, Takeru
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer

基于拷贝数的癌基因优势可能提示 HER2 阳性胃癌中 ERBB2 依赖性和曲妥珠单抗反应

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-026-01204-5
Wakatsuki, Takeru; Yamamoto, Noriko; Ishizuka, Naoki; Hironaka, Shuichi; Minashi, Keiko; Kadowaki, Shigenori; Hirano, Hidekazu; Shoji, Hirokazu; Yamaguchi, Toshifumi; Chin, Keisho; Ogura, Mariko; Nakayama, Izuma; Osumi, Hiroki; Ueki, Arisa; Kitano, Shigehisa; Boku, Narikazu; Yamaguchi, Kensei; Takahari, Daisuke
胃癌
肿瘤
HER2
肿瘤免疫
ERBB2
发表日期：2026
文献求助 收藏

Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer

药房门诊随访对维持接受CAPOX辅助化疗的胃癌患者相对剂量强度的重要性

期刊:Molecular and Clinical Oncology
影响因子:1.4
doi:10.3892/mco.2026.2943
Nakamura, Masashi; Yokokawa, Takashi; Kawakami, Kazuyoshi; Kimura, Yuka; Shimizu, Hisanori; Kobayashi, Kazuo; Aoyama, Takeshi; Suzuki, Wataru; Hatori, Masahiro; Suzuki, Kenichi; Takahari, Daisuke; Ogura, Mariko; Chin, Keisho; Wakatsuki, Takeru; Yamaguchi, Kensei; Yamaguchi, Masakazu
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

2011年至2023年，HER2阳性晚期胃癌患者的真实世界治疗选择增加，生存率提高。

期刊:
影响因子:
doi:10.1177/17562848261441026
Shimozaki, Keitaro; Ooki, Akira; Yoshikawa, Kaoru; Yoshino, Koichiro; Udagawa, Shohei; Osumi, Hiroki; Fukuoka, Shota; Wakatsuki, Takeru; Ogura, Mariko; Takahari, Daisuke; Shinozaki, Eiji; Chin, Keisho; Yamaguchi, Kensei
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer

IL33-ST2轴是晚期胃癌抗PD-1治疗疗效的预测性生物标志物

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-07145-3
Kudo-Saito, Chie; Imazeki, Hiroshi; Nagashima, Kengo; Shoji, Hirokazu; Tsugaru, Kai; Takahashi, Naoki; Kawakami, Takeshi; Amanuma, Yusuke; Wakatsuki, Takeru; Okano, Naohiro; Narita, Yukiya; Yamamoto, Yoshiyuki; Kizawa, Rika; Muro, Kei; Ichikawa, Hitoshi; Boku, Narikazu
胃癌
肿瘤
肿瘤免疫
IL3
PD-1
发表日期：2025
文献求助 收藏

The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancer.

FSTL1-DIP2A 轴是预测晚期胃癌抗 PD-1 治疗效果的重要生物标志物。

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04239-1
Kudo-Saito Chie, Imazeki Hiroshi, Nagashima Kengo, Shoji Hirokazu, Tsugaru Kai, Takahashi Naoki, Kawakami Takeshi, Amanuma Yusuke, Wakatsuki Takeru, Nagashima Fumio, Narita Yukiya, Yamamoto Yoshiyuki, Kizawa Rika, Muro Kei, Boku Narikazu
胃癌
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

调查免疫疗法在2011年至2023年间对HER2阴性晚期胃癌患者的真实世界治疗中的作用

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251322670
Shimozaki, Keitaro; Ooki, Akira; Yoshino, Koichiro; Tamba, Mikako; Udagawa, Shohei; Osumi, Hiroki; Fukuoka, Shota; Nakayama, Izuma; Wakatsuki, Takeru; Ogura, Mariko; Takahari, Daisuke; Shinozaki, Eiji; Chin, Keisho; Yamaguchi, Kensei
胃癌
肿瘤
肿瘤免疫
HER2
免疫/内分泌
发表日期：2025
文献求助 收藏

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

循环肿瘤DNA在HER2阳性晚期胃癌中的临床意义：一项双重HER2和PD-1靶向治疗Ib期试验的合作研究（Ni-High）

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251367344
Osumi, Hiroki; Wakatsuki, Takeru; Ooki, Akira; Chin, Keisho; Shoji, Hirokazu; Ogura, Mariko; Nakayama, Izuma; Yamamoto, Noriko; Hirano, Hidekazu; Hara, Hiroki; Minashi, Keiko; Shinozaki, Eiji; Kato, Ken; Ishizuka, Naoki; Kitano, Shigehisa; Takeuchi, Kengo; Boku, Narikazu; Yamaguchi, Kensei; Takahari, Daisuke
胃癌
肿瘤
HER2
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma

新辅助多西他赛、顺铂和5-氟尿嘧啶治疗局部晚期食管鳞状细胞癌的真实世界安全性和有效性

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14011-4
Tamba, Mikako; Osumi, Hiroki; Ogura, Mariko; Fukuoka, Shota; Okamura, Akihiko; Kanamori, Jun; Imamura, Yu; Yoshino, Koichiro; Udagawa, Shohei; Wakatsuki, Takeru; Shinozaki, Eiji; Watanabe, Masayuki; Yamaguchi, Kensei; Chin, Keisho; Ooki, Akira
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Peripheral SNCA(+) cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer

外周SNCA(+)细胞是晚期胃癌患者接受纳武利尤单抗治疗预后不良的因素

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-03817-0
Kudo-Saito, Chie; Imazeki, Hiroshi; Nagashima, Kengo; Shoji, Hirokazu; Tsugaru, Kai; Takahashi, Naoki; Kawakami, Takeshi; Amanuma, Yusuke; Wakatsuki, Takeru; Okano, Naohiro; Narita, Yukiya; Yamamoto, Yoshiyuki; Kizawa, Rika; Muro, Kei; Boku, Narikazu
胃癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏